The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

The Globe and Mail has
updated our Stock Quote Pages
You are about to experience the newly designed Stock Quote Pages format. With the new layout, you'll enjoy a more in-depth look at the companies you're following and pages that are easier to navigate. This Editors' blog post explains why we've made these changes.

 

DexCom Inc

Nasdaq: DXCM
Last

(U.S.) $62.34

Today's change0.00 0.00%
Updated March 31 4:00 PM EDT. Delayed by at least 15 minutes.
 

DexCom Inc

Nasdaq: DXCM
Last

(U.S.) $62.34

Today's change0.00 0.00%
Updated March 31 4:00 PM EDT. Delayed by at least 15 minutes.

DexCom Inc closed at (U.S.)$62.34.

Over the last five days, shares have gained 1.84% and are currently 3.56% off of the 52-week high. Shares have outperformed the S&P 500 by 40.28% during the last year.

Key company metrics

  • Open(U.S.) $0.00
  • Previous close(U.S.) $62.34
  • High--
  • Low--
  • Bid / Ask(U.S.) $59.14 / (U.S.) $63.80
  • YTD % change+13.24%
  • Volume0
  • Average volume (10-day)607,726
  • Average volume (1-month)748,768
  • Average volume (3-month)669,686
  • 52-week range(U.S.) $28.09 to (U.S.) $64.64
  • Beta0.42
  • Trailing P/ENegative, not meaningful
  • P/E 1 year forward4,687.22×
  • Forward PEG156.24×
  • Indicated annual dividend--
  • Dividend yield0.00%
  • Trailing EPS(U.S.) -$0.30
Updated March 31 4:00 PM EDT. Delayed by at least 15 minutes.
S&P TSX0.00%Sector:HealthcareIndustry:Medical Equipment, Supplies & Distribution
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q4/2014Q3/2014Q2/2014Q1/2014
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedDec 31, 201412/31/2014Sep 30, 201409/30/2014Jun 30, 201406/30/2014Mar 31, 201403/31/2014
Revenue84695947
Total other revenue--------
Total revenue84695947
Gross profit59474030
Total cost of revenue25221917
Total operating expense83746559
Selling / general / administrative36343128
Research & development22191515
Depreciation / amortization--------
Interest expense (income), net operating--------
Unusual expense (income)--------
Other operating expenses, total--------
Operating income2-5-6-12
Interest income (expense), net non-operating0000
Gain (loss) on sale of assets--------
Other--------
Income before tax1-5-6-13
Income after tax1-5-6-13
Income tax, total0000
Net income1-5-6-13
Total adjustments to net income--------
Net income before extra. items1-5-6-13
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items1-5-6-13
Inc. avail. to common incl. extra. items1-5-6-13
Diluted net income1-5-6-13
Dilution adjustment0000
Diluted weighted average shares77767573
Diluted EPS excluding extraordinary itemsvalue per share0.02-0.07-0.08-0.17
Dividends per sharevalue per share0.000.000.000.00
Diluted normalized EPSvalue per share0.02-0.07-0.08-0.17